Tesla – Shares dropped 1.9% after Goldman Sachs became the latest Wall Street bank to downgrade the electric-vehicle maker to neutral from buy. Goldman cited the difficult pricing environment for electric vehicles, as well as the stock’s recent run up, for the call.
Moderna – The drugmaker gained 2.5% following an upgrade by UBS to buy from neutral. The bank said the stock’s current valuation isn’t pricing in potential upside from other vaccines. UBS cut its price target to $191 from $221, which still implies 61% upside from Friday’s close.
